A single center,open-lable,self-controlled clinical study of MEBO in the treatment of recessive dystrophic epidermolysis bullosa
BEB6678
Ms. Yang Yu
Shantou MEBO Pharmaceutical Co., Ltd, China
Shantou MEBO Pharmaceutical Co., Ltd, China
Currently, there is no question has been asked, you are welcome to ask a question.
Return